Cargando…
DHA brain uptake and APOE4 status: a PET study with [1-(11)C]-DHA
BACKGROUND: The apolipoprotein E ɛ4 (APOE4) allele is the strongest genetic risk factor identified for developing Alzheimer’s disease (AD). Among brain lipids, alteration in the ω-3 polyunsaturated fatty acid docosahexaenoic acid (DHA) homeostasis is implicated in AD pathogenesis. APOE4 may influenc...
Autores principales: | Yassine, Hussein N., Croteau, Etienne, Rawat, Varun, Hibbeln, Joseph R., Rapoport, Stanley I., Cunnane, Stephen C., Umhau, John C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364667/ https://www.ncbi.nlm.nih.gov/pubmed/28335828 http://dx.doi.org/10.1186/s13195-017-0250-1 |
Ejemplares similares
-
The effect of APOE genotype on the delivery of DHA to cerebrospinal fluid in Alzheimer’s disease
por: Yassine, Hussein N., et al.
Publicado: (2016) -
Brain Docosahexaenoic Acid [DHA] Incorporation and Blood Flow Are Increased in Chronic Alcoholics: A Positron Emission Tomography Study Corrected for Cerebral Atrophy
por: Umhau, John C., et al.
Publicado: (2013) -
The Influence of APOE Genotype, DHA, and Flavanol Intervention on Brain DHA and Lipidomics Profile in Aged Transgenic Mice
por: Martinsen, Anneloes, et al.
Publicado: (2023) -
LPC-DHA/EPA-Enriched Diets Increase Brain DHA and Modulate Behavior in Mice That Express Human APOE4
por: Scheinman, Sarah B., et al.
Publicado: (2021) -
A maternal erythrocyte DHA content of approximately 6 g% is the DHA status at which intrauterine DHA biomagnifications turns into bioattenuation and postnatal infant DHA equilibrium is reached
por: Luxwolda, Martine F., et al.
Publicado: (2011)